Compare
PPG Industries Inc vs Kenvue Inc. vs Estee Lauder Companies Inc vs Teva Pharmaceutical Industries Ltd
| Latest fiscal year | PPG Industries Inc PPG | Kenvue Inc. KVUE | Estee Lauder Companies Inc EL | Teva Pharmaceutical Industries Ltd TEVA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-28 | 2026-06-30 | 2025-12-31 |
| Revenue | $15.88B | $15.12B | $15.05B | $17.26B |
| Revenue growth (YoY) | +0.2% | -2.1% | +5.0% | +4.3% |
| Gross margin | 41.3% (computed) | 58.1% | 75.5% | 51.8% |
| Operating margin | n/a | 16.0% | 5.2% | 12.5% |
| Net margin | 9.9% | 9.7% | 1.2% | 8.2% |
| Net income | $1.58B | $1.47B | $182.00M | $1.41B |
| EPS (Diluted) | $6.94 | $0.76 | $0.50 | $1.21 |
| Operating cash flow | $1.94B | $2.20B | $1.77B | $1.65B |
| Free cash flow | $1.16B | $1.72B | $1.32B | $1.15B |
| Cash & equivalents | $2.16B | $1.06B | n/a | $3.56B |
| Total assets | $22.10B | $27.08B | $19.76B | $40.75B |
| Total liabilities | $14.00B | $16.31B | n/a | $32.83B |
| Shareholders' equity | $8.10B | $10.77B | $3.81B | $7.91B |
| Return on year-end equity | 19.5% | 13.7% | 4.8% | 17.8% |
| Shares outstanding | 223.43M | 1.92B | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | PPG Industries Inc | Kenvue Inc. | Estee Lauder Companies Inc | Teva Pharmaceutical Industries Ltd |
|---|---|---|---|---|
| Latest | $15.88B Ended 2025-12-31 | $15.12B Ended 2025-12-28 | $15.05B Ended 2026-06-30 | $17.26B Ended 2025-12-31 |
| 1 year earlier | $15.85B Ended 2024-12-31 | $15.46B Ended 2024-12-29 | $14.33B Ended 2025-06-30 | $16.54B Ended 2024-12-31 |
| 2 years earlier | $16.24B Ended 2023-12-31 | $15.44B Ended 2023-12-31 | $15.61B Ended 2024-06-30 | $15.85B Ended 2023-12-31 |
| 3 years earlier | $15.61B Ended 2022-12-31 | $14.95B Ended 2023-01-01 | $15.91B Ended 2023-06-30 | $14.93B Ended 2022-12-31 |
| 4 years earlier | $16.80B Ended 2021-12-31 | $15.05B Ended 2022-01-02 | $17.74B Ended 2022-06-30 | $15.88B Ended 2021-12-31 |